Hydroxychloroquine with thyroid hormone for recurrent pregnancy loss
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a combination of hydroxychloroquine (an anti-inflammatory drug) and levothyroxine (thyroid hormone) can improve live birth rates in women with recurrent pregnancy loss, normal thyroid function, and TPO antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 20 and 40 years old.
- You have had at least two pregnancy losses (including biochemical pregnancy) with the same partner.
- You and your partner have normal chromosome tests (no genetic abnormalities).
- You have a positive TPO antibody test (a thyroid antibody) but your thyroid hormone levels are normal.
- You do not have other autoimmune diseases, diabetes, high blood pressure, cancer, or severe kidney/liver problems.
- You are not currently taking steroids or immunosuppressant drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called prednisolone can help prevent further miscarriages in people who have had recurrent miscarriages with no known cause. If you qualify, you would take prednisolone early in pregnancy and the study team would watch whether more losses occur.
This study follows couples who have experienced two or more pregnancy losses to learn more about their health and outcomes. It may help find ways to improve care for people with recurrent pregnancy loss.
This study explores a new supportive care program for people who have had multiple pregnancy losses and are pregnant again. It aims to see if extra attention and care can help reduce the risk of another loss.
This trial tests whether taking prednisolone, a steroid medicine, can improve immune cell activity in the uterus in women who have had 3 or more miscarriages. If it works, it could help reduce the chance of future pregnancy loss.
This trial tests whether taking thyroid hormone (levothyroxine) can help prevent another pregnancy loss in women who have had multiple losses and have a low free T4 level with normal TSH. It aims to see if this treatment improves pregnancy outcomes.
This study tests whether giving thyroid hormone to pregnant women with mildly elevated TSH levels (but normal thyroid antibodies) helps improve pregnancy outcomes. Participation could provide extra monitoring and care during pregnancy.
Hear when a new Recurrent Pregnancy Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.